Physician
Malak, Joseph
Malak, Joseph was paid $6.34M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoMALAK, JOSEPH
POUGHKEEPSIE, NY 12601
POUGHKEEPSIE, NY 12601
33aNPI1497723878assigned 03/10/2006
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$6.34M
24GClaims157,876
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in New York
Rank by total paid#7 of 161
Median peer was paid$100K
This provider vs. median63×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,045 | $278K | |
| 2019 | 12,199 | $418K | |
| 2020 | 17,491 | $639K | |
| 2021 | 33,218 | $1.25M | |
| 2022 | 34,319 | $1.44M | |
| 2023 | 26,540 | $1.18M | |
| 2024incomplete | 29,064 | $1.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 26,221 | 23,060 | $1.90M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 12,827 | 11,629 | $1.30M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.2% | 5,870 | 5,865 | $522K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.7% | 4,843 | 4,839 | $424K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6.3% | 3,603 | 3,435 | $401K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.9% | 4,545 | 4,215 | $376K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.4% | 6,050 | 5,631 | $282K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 2,227 | 2,226 | $214K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.2% | 5,104 | 4,870 | $140K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.9% | 12,526 | 10,618 | $118K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.8% | 7,458 | 6,920 | $114K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 1,676 | 1,568 | $71K |
59 more codes
| 87631 | 1.0% | 691 | $65K | |
| 92552 | <1% | 6,664 | $57K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 349 | $51K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 3,971 | $48K |
| 99381 | <1% | 487 | $44K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 2,479 | $34K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,659 | $33K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,530 | $31K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 9,368 | $15K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 297 | $11K |
| 83655 | <1% | 780 | $10K | |
| 0002A | <1% | 168 | $6K | |
| 92551 | <1% | 1,679 | $6K | |
| 92567 | <1% | 549 | $6K | |
| 0071A | <1% | 141 | $5K | |
| 99382 | <1% | 54 | $5K | |
| 69210 | <1% | 161 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 53 | $5K |
| 96160 | <1% | 2,284 | $4K | |
| 99383 | <1% | 37 | $3K | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 213 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 64 | $3K |
| 96161 | <1% | 1,447 | $3K | |
| 87634 | <1% | 120 | $3K | |
| 87807 | <1% | 193 | $3K | |
| 96127 | <1% | 423 | $2K | |
| 0001A | <1% | 39 | $1K | |
| 90461 | <1% | 477 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $1K |
| 81003 | <1% | 518 | $1K | |
| 0072A | <1% | 14 | $535.46 | |
| 99051 | <1% | 34 | $451.50 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 24 | $433.30 |
| 86769 | <1% | 12 | $427.21 | |
| 99173 | <1% | 8,294 | $312.10 | |
| 81002 | <1% | 118 | $238.92 | |
| 90716 | <1% | 296 | $198.31 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 36 | $174.10 |
| 90707 | <1% | 329 | $80.00 | |
| 90713 | <1% | 300 | $80.00 | |
| 90744 | <1% | 276 | $80.00 | |
| 90700 | <1% | 502 | $70.00 | |
| 94760 | <1% | 5,487 | $60.51 | |
| 90715 | <1% | 54 | $60.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15 | $56.56 |
| 90734 | <1% | 61 | $30.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 44 | $2.34 |
| 91300 | 0% | 224 | $0.00 | |
| 90756 | 0% | 13 | $0.00 | |
| 90670 | 0% | 100 | $0.00 | |
| 99072 | 0% | 270 | $0.00 | |
| 90661 | 0% | 16 | $0.00 | |
| 90648 | 0% | 13 | $0.00 | |
| 99000 | 0% | 1,196 | $0.00 | |
| 36416 | 0% | 895 | $0.00 | |
| 90619 | 0% | 57 | $0.00 | |
| 90686 | 0% | 145 | $0.00 | |
| 90677 | 0% | 12 | $0.00 | |
| 91307 | 0% | 181 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.